These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30450803)

  • 1. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
    Yang J; He Z; Li M; Hong T; Ouyang T
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
    Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
    Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
    Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
    J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases.
    Leader A; Hamulyák EN; Carney BJ; Avrahami M; Knip JJ; Rozenblatt S; Beenen LFM; Yust-Katz S; Icht O; Coppens M; Raanani P; Middeldorp S; Büller HR; Zwicker JI; Spectre G
    Blood Adv; 2020 Dec; 4(24):6291-6297. PubMed ID: 33351124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
    Swartz AW; Drappatz J
    Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases.
    Abdelmessih E; Ahuja T; Wo S; Sango A; Papadopoulos J; Green D; Xiang E
    J Thromb Thrombolysis; 2024 Mar; 57(3):418-427. PubMed ID: 38281232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
    Lee A; Oley F; Lo M; Fong R; McGann M; Saunders I; Block S; Mahajan A; Pon TK
    Thromb Res; 2021 Dec; 208():148-155. PubMed ID: 34798446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials.
    Brunetti ND; Tricarico L; Correale M; De Gennaro L; Santoro F; Ieva R; Di Biase M
    J Thromb Thrombolysis; 2020 Aug; 50(2):305-310. PubMed ID: 31654194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
    Jo J; Donahue J; Sarai G; Petroni G; Schiff D
    Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
    Rojas-Hernandez CM; Oo TH; García-Perdomo HA
    J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis.
    Giustozzi M; Proietti G; Becattini C; Roila F; Agnelli G; Mandalà M
    Blood Adv; 2022 Aug; 6(16):4873-4883. PubMed ID: 35772127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
    Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
    Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
    Pernod G; Joly M; Sonnet B
    J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
    Diaz M; Jo J
    Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
    Vitale FV; Rotondo S; Sessa E; Parisi A; Giaimo V; D'Angelo A; Antonelli G; Romeo P; Ferraù F
    J Oncol Pharm Pract; 2012 Mar; 18(1):10-6. PubMed ID: 21228085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.